共 50 条
- [11] Re: Early Development of the Metabolic Syndrome after Chemotherapy for Testicular Cancer Editorial Comment JOURNAL OF UROLOGY, 2014, 191 (04): : 987 - 987
- [14] Re: Single-Nucleotide Polymorphism in the 5-α-Reductase Gene (SRD5A2) is Associated with Increased Prevalence of Metabolic Syndrome in Chemotherapy-Treated Testicular Cancer Survivors JOURNAL OF UROLOGY, 2016, 196 (06): : 1677 - 1678
- [15] Re: Congenital Malformations and Testicular Germ Cell Tumors Editorial Comment JOURNAL OF UROLOGY, 2014, 192 (05): : 1423 - 1423
- [16] Risk of osteoporosis in testicular germ cell tumour survivors: A systematic review of the literature BJUI COMPASS, 2023, 4 (01): : 24 - 43
- [17] Re: Risk of Solid Cancer after Treatment of Testicular Germ Cell Cancer in the Platinum Era Editorial Comment JOURNAL OF UROLOGY, 2019, 201 (03): : 445 - 445
- [18] Re: Phenotypic Characterisation of Immune Cell Infiltrates in Testicular Germ Cell Neoplasia Editorial Comment JOURNAL OF UROLOGY, 2015, 194 (02): : 396 - 396
- [19] Re: Bilateral Testicular Germ Cell Tumors in the Era of Multimodal Therapy Editorial Comment JOURNAL OF UROLOGY, 2018, 200 (06): : 1167 - 1167
- [20] Re: Burden of Testicular, Paratesticular and Extragonadal Germ Cell Tumours in Europe Editorial Comment JOURNAL OF UROLOGY, 2012, 188 (03): : 815 - 816